[Corpus luteum function in the middle luteal phase following treatment with prostaglandins].
The corpus luteum of the mid-luteal phase was examined concerning of the signs of functional and morphological regression after treatment with Prostin F2alpha and 15(S)-15-methyl-PGF2alpha. By 8 patients who were operated upon out of various uterine indications steroid hormone levels were determined during the treatment with prostaglandins and corpus luteum was judged by electron-microscopy. Morphological changes in the temporary decrease of the progesteron concentration could be found.
D003338:Corpus Luteum / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D003341:Luteolysis; D011374:Progesterone / Q000097:blood; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*
D011461:Prostaglandins F, Synthetic; D011374:Progesterone; D004958:Estradiol
Untersuchungen zur Funktion des Corpus luteum in der mittleren Lutealphase nach Behandlung mit Prostaglandinen.